• Review highlights gut microbiota's role in immunotherapy response, especially for MSI-H tumors

    A comprehensive review evaluates how gut microbiota and microbial metabolites influence colorectal cancer development, the tumor microenvironment, and immunotherapy responses, with emphasis on strategies for proficient mismatch repair/microsatellite-stable tumors where efficacy remains limited. (Life Sciences)